Guangzhou Darui Biotechnology
Provider of platforms for research and diagnostic applications
About This Fund
Guangzhou Darui Biotechnology is a corporate investor (Suite,) founded in 2015 and headquartered in Guangzhou, Guangdong, china. Provider of platforms for research and diagnostic applications. The company offers products and instruments for prenatal screening, newborn screening, tumor screening, infectious disease testing, and sex hormone testing. The company has developed platforms such as a high-throughput sequencing platform, CD-DST platform, tandem mass spectrometry platform, nucleic acid mass spectrometry platform, gene chip platform, and core raw material platform. Practice areas include Life Sciences. The firm operates as Genomics and Life Sciences Platforms and Tools. Key investment sectors include Semiconductors.
Investment Focus
Preparing to pitch Guangzhou Darui Biotechnology?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →